US Stock MarketDetailed Quotes

Pacific Biosciences of California (PACB)

Watchlist
  • 1.630
  • +0.030+1.88%
Close Apr 16 16:00 ET
  • 1.630
  • 0.0000.00%
Post 19:33 ET
492.26MMarket Cap-0.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacific Biosciences of California (PACB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.03%-111.21M
37.78%-19.07M
58.85%-18.71M
45.86%-29.38M
41.79%-44.06M
20.49%-206.06M
46.75%-30.65M
30.25%-45.46M
-30.00%-54.26M
20.07%-75.68M
Net income from continuing operations
-76.34%-546.38M
-1,802.70%-40.37M
37.42%-38M
75.81%-41.93M
-445.01%-426.08M
-1.02%-309.85M
102.89%2.37M
9.19%-60.73M
-148.19%-173.32M
11.18%-78.18M
Depreciation and amortization
624.28%386.41M
-57.54%4.65M
-72.66%4.4M
-67.93%4.58M
3,002.87%372.78M
101.07%53.35M
-6.41%10.95M
195.12%16.1M
193.77%14.29M
166.03%12.01M
Deferred tax
-166.34%-546K
--0
--0
--0
---546K
98.21%-205K
71.45%-205K
--0
--0
--0
Other non cash items
89.09%-17.01M
100.15%232K
-72.99%397K
13.71%340K
-5,499.70%-17.98M
-898.84%-155.89M
-10,688.94%-157.99M
-57.04%1.47M
-84.91%299K
-97.36%333K
Change In working capital
110.95%4.44M
-10.45%7.49M
118.57%3.21M
38.84%-3.87M
90.58%-2.39M
31.17%-40.58M
208.10%8.37M
-37.10%-17.27M
-240.43%-6.33M
41.23%-25.35M
-Change in receivables
-187.16%-7.92M
-359.92%-4.83M
-46.20%1.64M
71.00%-612K
-165.50%-4.12M
150.99%9.09M
130.33%1.86M
147.27%3.05M
-137.98%-2.11M
158.24%6.29M
-Change in inventory
82.94%-1.42M
-50.42%3.51M
-177.06%-1.06M
73.98%-1.33M
78.22%-2.54M
39.89%-8.32M
-21.47%7.07M
143.64%1.37M
19.92%-5.11M
12.49%-11.66M
-Change in prepaid assets
282.14%8.51M
154.90%717K
4,052.00%988K
565.94%3.38M
12.29%3.43M
124.80%2.23M
23.04%-1.31M
97.92%-25K
-36.74%508K
144.29%3.05M
-Change in payables and accrued expense
122.62%5.64M
58.86%6.28M
125.22%2.28M
38.28%-1.7M
92.90%-1.21M
-287.37%-24.94M
-58.63%3.95M
-265.48%-9.03M
-142.82%-2.75M
-110.75%-17.11M
-Change in other current liabilities
97.16%-470K
1,161.67%2.41M
95.05%-518K
-282.73%-3.09M
109.67%728K
21.99%-16.53M
98.24%-227K
-122.72%-10.47M
99.18%1.69M
-70.16%-7.53M
-Change in other working capital
104.79%101K
80.42%-584K
94.33%-123K
-136.26%-524K
-16.80%1.33M
79.77%-2.11M
46.28%-2.98M
14.86%-2.17M
152.74%1.45M
278.49%1.6M
Cash from discontinued investing activities
Operating cash flow
46.03%-111.21M
37.78%-19.07M
58.85%-18.71M
45.86%-29.38M
41.79%-44.06M
20.49%-206.06M
46.75%-30.65M
30.25%-45.46M
-30.00%-54.26M
20.07%-75.68M
Investing cash flow
Cash flow from continuing investing activities
-6.90%115.45M
-55.31%26.03M
-18.05%18.9M
-67.10%25.28M
232.51%45.23M
2,593.40%124M
187.48%58.24M
-90.48%23.07M
177.94%76.84M
52.95%-34.14M
Net PPE purchase and sale
56.14%-2.71M
46.75%-861K
-89.07%86K
62.81%-550K
64.19%-1.39M
30.02%-6.19M
20.11%-1.62M
194.82%787K
34.79%-1.48M
-4.25%-3.88M
Net intangibles purchase and sale
---5M
--0
--0
--0
---5M
--0
--0
--0
--0
--0
Net business purchase and sale
--0
----
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
-5.40%123.16M
-55.07%26.89M
-15.54%18.82M
-67.01%25.83M
270.62%51.62M
860.90%130.19M
192.73%59.86M
-90.84%22.28M
181.31%78.32M
56.04%-30.26M
Cash from discontinued investing activities
Investing cash flow
-6.90%115.45M
-55.31%26.03M
-18.05%18.9M
-67.10%25.28M
232.51%45.23M
2,593.40%124M
187.48%58.24M
-90.48%23.07M
177.94%76.84M
52.95%-34.14M
Financing cash flow
Cash flow from continuing financing activities
107.97%3.43M
0
80.91%1.47M
0
-70.11%1.96M
-139.48%-42.99M
38.48%-50.2M
203.97%812K
96.78%-152K
-96.66%6.55M
Net issuance payments of debt
--0
--0
--0
--0
--0
73.40%-490K
--0
--0
67.31%-152K
24.22%-338K
Net common stock issuance
--0
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-55.50%3.43M
--0
80.91%1.47M
--0
-71.57%1.96M
-49.72%7.7M
--0
-82.20%812K
--0
-4.75%6.89M
Net other financing activities
----
----
----
----
----
46.47%-50.2M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
107.97%3.43M
--0
80.91%1.47M
--0
-70.11%1.96M
-139.48%-42.99M
38.48%-50.2M
203.97%812K
96.78%-152K
-96.66%6.55M
Net cash flow
Beginning cash position
-68.47%57.59M
-27.31%58.3M
-44.36%56.64M
-23.67%58.51M
-68.47%57.59M
-44.37%182.63M
-79.35%80.2M
-51.99%101.79M
-78.34%76.65M
-44.37%182.63M
Current changes in cash
106.13%7.67M
130.78%6.96M
107.71%1.66M
-118.26%-4.09M
103.04%3.14M
14.17%-125.04M
89.01%-22.61M
-112.24%-21.59M
115.46%22.42M
-459.25%-103.27M
End cash Position
13.31%65.26M
13.31%65.26M
-27.31%58.3M
-44.36%56.64M
-23.67%58.51M
-68.47%57.59M
-68.47%57.59M
-79.35%80.2M
-51.99%101.79M
-78.34%76.65M
Free cash flow
43.97%-118.92M
38.23%-19.93M
58.32%-18.62M
46.31%-29.93M
36.60%-50.45M
20.81%-212.25M
45.85%-32.27M
32.32%-44.68M
-26.66%-55.74M
19.16%-79.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.03%-111.21M37.78%-19.07M58.85%-18.71M45.86%-29.38M41.79%-44.06M20.49%-206.06M46.75%-30.65M30.25%-45.46M-30.00%-54.26M20.07%-75.68M
Net income from continuing operations -76.34%-546.38M-1,802.70%-40.37M37.42%-38M75.81%-41.93M-445.01%-426.08M-1.02%-309.85M102.89%2.37M9.19%-60.73M-148.19%-173.32M11.18%-78.18M
Depreciation and amortization 624.28%386.41M-57.54%4.65M-72.66%4.4M-67.93%4.58M3,002.87%372.78M101.07%53.35M-6.41%10.95M195.12%16.1M193.77%14.29M166.03%12.01M
Deferred tax -166.34%-546K--0--0--0---546K98.21%-205K71.45%-205K--0--0--0
Other non cash items 89.09%-17.01M100.15%232K-72.99%397K13.71%340K-5,499.70%-17.98M-898.84%-155.89M-10,688.94%-157.99M-57.04%1.47M-84.91%299K-97.36%333K
Change In working capital 110.95%4.44M-10.45%7.49M118.57%3.21M38.84%-3.87M90.58%-2.39M31.17%-40.58M208.10%8.37M-37.10%-17.27M-240.43%-6.33M41.23%-25.35M
-Change in receivables -187.16%-7.92M-359.92%-4.83M-46.20%1.64M71.00%-612K-165.50%-4.12M150.99%9.09M130.33%1.86M147.27%3.05M-137.98%-2.11M158.24%6.29M
-Change in inventory 82.94%-1.42M-50.42%3.51M-177.06%-1.06M73.98%-1.33M78.22%-2.54M39.89%-8.32M-21.47%7.07M143.64%1.37M19.92%-5.11M12.49%-11.66M
-Change in prepaid assets 282.14%8.51M154.90%717K4,052.00%988K565.94%3.38M12.29%3.43M124.80%2.23M23.04%-1.31M97.92%-25K-36.74%508K144.29%3.05M
-Change in payables and accrued expense 122.62%5.64M58.86%6.28M125.22%2.28M38.28%-1.7M92.90%-1.21M-287.37%-24.94M-58.63%3.95M-265.48%-9.03M-142.82%-2.75M-110.75%-17.11M
-Change in other current liabilities 97.16%-470K1,161.67%2.41M95.05%-518K-282.73%-3.09M109.67%728K21.99%-16.53M98.24%-227K-122.72%-10.47M99.18%1.69M-70.16%-7.53M
-Change in other working capital 104.79%101K80.42%-584K94.33%-123K-136.26%-524K-16.80%1.33M79.77%-2.11M46.28%-2.98M14.86%-2.17M152.74%1.45M278.49%1.6M
Cash from discontinued investing activities
Operating cash flow 46.03%-111.21M37.78%-19.07M58.85%-18.71M45.86%-29.38M41.79%-44.06M20.49%-206.06M46.75%-30.65M30.25%-45.46M-30.00%-54.26M20.07%-75.68M
Investing cash flow
Cash flow from continuing investing activities -6.90%115.45M-55.31%26.03M-18.05%18.9M-67.10%25.28M232.51%45.23M2,593.40%124M187.48%58.24M-90.48%23.07M177.94%76.84M52.95%-34.14M
Net PPE purchase and sale 56.14%-2.71M46.75%-861K-89.07%86K62.81%-550K64.19%-1.39M30.02%-6.19M20.11%-1.62M194.82%787K34.79%-1.48M-4.25%-3.88M
Net intangibles purchase and sale ---5M--0--0--0---5M--0--0--0--0--0
Net business purchase and sale --0------------------0--0------------
Net investment purchase and sale -5.40%123.16M-55.07%26.89M-15.54%18.82M-67.01%25.83M270.62%51.62M860.90%130.19M192.73%59.86M-90.84%22.28M181.31%78.32M56.04%-30.26M
Cash from discontinued investing activities
Investing cash flow -6.90%115.45M-55.31%26.03M-18.05%18.9M-67.10%25.28M232.51%45.23M2,593.40%124M187.48%58.24M-90.48%23.07M177.94%76.84M52.95%-34.14M
Financing cash flow
Cash flow from continuing financing activities 107.97%3.43M080.91%1.47M0-70.11%1.96M-139.48%-42.99M38.48%-50.2M203.97%812K96.78%-152K-96.66%6.55M
Net issuance payments of debt --0--0--0--0--073.40%-490K--0--067.31%-152K24.22%-338K
Net common stock issuance --0------------------0--0--0--0--0
Proceeds from stock option exercised by employees -55.50%3.43M--080.91%1.47M--0-71.57%1.96M-49.72%7.7M--0-82.20%812K--0-4.75%6.89M
Net other financing activities --------------------46.47%-50.2M----------------
Cash from discontinued financing activities
Financing cash flow 107.97%3.43M--080.91%1.47M--0-70.11%1.96M-139.48%-42.99M38.48%-50.2M203.97%812K96.78%-152K-96.66%6.55M
Net cash flow
Beginning cash position -68.47%57.59M-27.31%58.3M-44.36%56.64M-23.67%58.51M-68.47%57.59M-44.37%182.63M-79.35%80.2M-51.99%101.79M-78.34%76.65M-44.37%182.63M
Current changes in cash 106.13%7.67M130.78%6.96M107.71%1.66M-118.26%-4.09M103.04%3.14M14.17%-125.04M89.01%-22.61M-112.24%-21.59M115.46%22.42M-459.25%-103.27M
End cash Position 13.31%65.26M13.31%65.26M-27.31%58.3M-44.36%56.64M-23.67%58.51M-68.47%57.59M-68.47%57.59M-79.35%80.2M-51.99%101.79M-78.34%76.65M
Free cash flow 43.97%-118.92M38.23%-19.93M58.32%-18.62M46.31%-29.93M36.60%-50.45M20.81%-212.25M45.85%-32.27M32.32%-44.68M-26.66%-55.74M19.16%-79.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -